Acelrx Pharmaceuticals, Inc.

CA · United States · Reporting entity ID 100000456811

Total reported 2019–2025

$2.65M

#932 of 2,960 reporting companies — 0% of all reported industry payments

$2.12M in general payments across 6,315 records, plus $531K in research funding across 27 records.

How it breaks down

General payments $2,115,828

Research funding $531,413

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.